TD Cowen Trims Elevance Health (NYSE:ELV) Target Price to $589.00
Elevance Health (NYSE:ELV – Free Report) had its price objective decreased by TD Cowen from $624.00 to $589.00 in a research report released on Friday morning, Benzinga reports. TD Cowen currently has a buy rating on the stock. Other research analysts have also recently issued research reports about the company. Truist Financial lifted their target […]
More Stories
Massive 2026 Democrat Election Fraud in Every State — And the Party That Let It Happen
By Stephen Zogopoulos, USNN World News They didn’t just cheat.They robbed the country in broad daylight — and the Democrat...
Over Arizona’s Red Rock Country, Balloons Take to the Skies
By Allan Stein PAGE, Ariz.—Scattered cheers rang out across the golf course as a small red test balloon drifted into...
Trump Orders DOJ to Probe Alleged Threats by Democrats Against Conservatives
By Tom Gantert President Donald Trump said he’s ordering the Justice Department to investigate Democratic political leaders he says have...
OpenAI Pledges to Cover Data Centers’ Full Energy Costs
By Bill Pan OpenAI said it will pay the full energy costs of future data centers it owns and operates,...
Amid Calls for a Nationwide Wealth Tax, Critics Warn of Lost Investment and Jobs
By Kevin Stocklin Although California voters rejected the state’s proposed “billionaire’s tax” at the midterm ballot box, politicians and groups...
Israeli President Hands Opposition Candidate First Chance at Forming Government
By Melanie Sun Israeli President Isaac Herzog on Saturday night said he would hand opposition leader Gadi Eisenkot the first...